A Transcriptional Program Mediating Entry into Cellular Quiescence

Por Liu, Helen, Adler, Adam S, Segal, Eran, Chang, Howard Y
Publicado em 2007

New discovery rarely runs smooth: an update on progranulin/TNFR interactions

Por Wang, Betty C., Liu, Helen, Talwar, Ankoor, Jian, Jinlong
Publicado no Protein Cell (2015)

Immuno-oncology safety education experience: Key lessons from ipilimumab (IPI)

Por Bartell, Heddy, Wolchok, Jedd, Hodi, F Stephen, Liu, Helen, Wojtaszek, Cynthia, Weber, Jeffrey
Publicado no J Immunother Cancer (2015)

Age-Related Changes in Orienting Attention in Time

Por Zanto, Theodore P., Pan, Peter, Liu, Helen, Bollinger, Jacob, Nobre, Anna C., Gazzaley, Adam
Publicado em 2011

Module map of stem cell genes guides creation of epithelial cancer stem cells

Por Wong, David J., Liu, Helen, Ridky, Todd W., Cassarino, David, Segal, Eran, Chang, Howard Y.
Publicado em 2008

Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer

Por Wang, Shu-Lian, Liao, Zhongxing, Liu, Helen, Ajani, Jaffer, Swisher, Stephen, Cox, James D, Komaki, Ritsuko
Publicado em 2006

The histone demethylase UTX enables RB-dependent cell fate control

Por Wang, Jordon K., Tsai, Miao-Chih, Poulin, Gino, Adler, Adam S., Chen, Shuzhen, Liu, Helen, Shi, Yang, Chang, Howard Y.
Publicado em 2010

Putting the Pieces Together: Necrolytic Migratory Erythema and the Glucagonoma Syndrome

Por Halvorson, Stephanie A. C., Gilbert, Erin, Hopkins, R. Samuel, Liu, Helen, Lopez, Charles, Chu, Michael, Martin, Marie, Sheppard, Brett
Publicado em 2013

nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial

Por Tehfe, Mustapha, Dowden, Scot, Kennecke, Hagen, El-Maraghi, Robert, Lesperance, Bernard, Couture, Felix, Letourneau, Richard, Liu, Helen, Romano, Alfredo
Publicado no Adv Ther (2016)

Erratum to: nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial

Por Tehfe, Mustapha, Dowden, Scot, Kennecke, Hagen, El-Maraghi, Robert, Lesperance, Bernard, Couture, Felix, Letourneau, Richard, Liu, Helen, Romano, Alfredo
Publicado no Adv Ther (2016)

Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With nab-Paclitaxel and Gemcitabine: An Exploratory Analysis From a Phase 3 Study

Por Kunzmann, Volker, Ramanathan, Ramesh K., Goldstein, David, Liu, Helen, Ferrara, Stefano, Lu, Brian, Renschler, Markus F., Von Hoff, Daniel D.
Publicado no Pancreas (2017)

Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: phase III MPACT trial

Por Scheithauer, Werner, Ramanathan, Ramesh K., Moore, Malcolm, Macarulla, Teresa, Goldstein, David, Hammel, Pascal, Kunzmann, Volker, Liu, Helen, McGovern, Desmond, Romano, Alfredo, Von Hoff, Daniel D.
Publicado no J Gastrointest Oncol (2016)

A dermal HOX transcriptional program regulates site-specific epidermal fate

Por Rinn, John L., Wang, Jordon K., Allen, Nancy, Brugmann, Samantha A., Mikels, Amanda J., Liu, Helen, Ridky, Todd W., Stadler, H. Scott, Nusse, Roel, Helms, Jill A., Chang, Howard Y.
Publicado em 2008

Progranulin Recruits HSP70 to β-Glucocerebrosidase and Is Therapeutic Against Gaucher Disease

Por Jian, Jinlong, Tian, Qing-Yun, Hettinghouse, Aubryanna, Zhao, Shuai, Liu, Helen, Wei, Jianlu, Grunig, Gabriele, Zhang, Wujuan, Setchell, Kenneth D.R., Sun, Ying, Overkleeft, Herman S., Chan, Gerald L., Liu, Chuan-ju
Publicado no EBioMedicine (2016)

Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer

Por Chiorean, E Gabriela, Von Hoff, Daniel D, Tabernero, Josep, El-Maraghi, Robert, Ma, Wen Wee, Reni, Michele, Harris, Marion, Whorf, Robert, Liu, Helen, Li, Jack Shiansong, Manax, Victoria, Romano, Alfredo, Lu, Brian, Goldstein, David
Publicado no Br J Cancer (2016)

Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer

Por Chiorean, E Gabriela, Von Hoff, Daniel D, Tabernero, Josep, El-Maraghi, Robert, Wee Ma, Wen, Reni, Michele, Harris, Marion, Whorf, Robert, Liu, Helen, Shiansong Li, Jack, Manax, Victoria, Romano, Alfredo, Lu, Brian, Goldstein, David
Publicado no Br J Cancer (2016)

Association Between Progranulin and Gaucher Disease

Por Jian, Jinlong, Zhao, Shuai, Tian, Qing-Yun, Liu, Helen, Zhao, Yunpeng, Chen, Wen-Chi, Grunig, Gabriele, Torres, Paola A., Wang, Betty C., Zeng, Bai, Pastores, Gregory, Tang, Wei, Sun, Ying, Grabowski, Gregory A., Kong, Max Xiangtian, Wang, Guilin, Chen, Ying, Liang, Fengxia, Overkleeft, Herman S., Saunders-Pullman, Rachel, Chan, Gerald L., Liu, Chuan-ju
Publicado no EBioMedicine (2016)